BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 12057931)

  • 1. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.
    Margetts PJ; Kolb M; Yu L; Hoff CM; Holmes CJ; Anthony DC; Gauldie J
    Am J Pathol; 2002 Jun; 160(6):2285-94. PubMed ID: 12057931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
    Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
    Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Koomen GC; Hart AA; ten Berge IJ; Struijk DG; Krediet RT
    J Lab Clin Med; 1993 Dec; 122(6):686-96. PubMed ID: 8245688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum.
    Margetts PJ; Bonniaud P; Liu L; Hoff CM; Holmes CJ; West-Mays JA; Kelly MM
    J Am Soc Nephrol; 2005 Feb; 16(2):425-36. PubMed ID: 15590759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal mesothelial cells produce inflammatory related cytokines.
    Yao V; Platell C; Hall JC
    ANZ J Surg; 2004 Nov; 74(11):997-1002. PubMed ID: 15550091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
    Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
    Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis.
    Kolb M; Margetts PJ; Anthony DC; Pitossi F; Gauldie J
    J Clin Invest; 2001 Jun; 107(12):1529-36. PubMed ID: 11413160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
    Lee CJ; Subeq YM; Lee RP; Liou HH; Hsu BG
    Cytokine; 2014 Jan; 65(1):105-18. PubMed ID: 24210651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of peritoneal effluents on mesothelial cells in culture: cell proliferation and extracellular matrix regulation.
    Perfumo F; Altieri P; Degl'Innocenti ML; Ghiggeri GM; Caridi G; Trivelli A; Gusmano R
    Nephrol Dial Transplant; 1996 Sep; 11(9):1803-9. PubMed ID: 8918626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine expression by neutrophils and macrophages in vivo: endotoxin induces tumor necrosis factor-alpha, macrophage inflammatory protein-2, interleukin-1 beta, and interleukin-6 but not RANTES or transforming growth factor-beta 1 mRNA expression in acute lung inflammation.
    Xing Z; Jordana M; Kirpalani H; Driscoll KE; Schall TJ; Gauldie J
    Am J Respir Cell Mol Biol; 1994 Feb; 10(2):148-53. PubMed ID: 8110470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
    Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S
    Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model.
    Mondello S; Mazzon E; Di Paola R; Crisafulli C; Mondello P; Buemi M; Aloisi C; Cuzzocrea S
    Shock; 2009 Sep; 32(3):332-9. PubMed ID: 19680075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent.
    McMasters KM; Cheadle WG
    J Surg Res; 1993 May; 54(5):426-30. PubMed ID: 8361168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model.
    Ertilav M; Hur E; Bozkurt D; Sipahi S; Timur O; Sarsik B; Akcicek F; Duman S
    Nephrology (Carlton); 2011 Aug; 16(6):552-7. PubMed ID: 21382127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
    Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
    Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.